Baxter (NYSE: BAX) reported Q2 EPS of $0.59, $0.02 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $2.82 billion.

GUIDANCE:

Baxter sees Q3 2025 EPS of $0.58-$0.62, versus the consensus of $0.64.

Baxter sees FY2025 EPS of $2.42-$2.52, versus the consensus of $2.52.

For earnings history and earnings-related data on Baxter (BAX) click here.